Zenosense, Inc. (ZENO) Well Positioned to Capitalize on Accelerated Market Penetration of Point-of-Care Diagnostics Devices

June 27, 2018 11:16:43
  • POC devices speed up triage, diagnosis and treatment of patients
  • MIDS Cardiac™ is being developed to detect the biomarker troponin I or T for suspected heart attack within 3 minutes, as opposed to often taking 60 minutes in central laboratories
  • Global cardiac biomarkers market expected to reach $13.3 billion by 2024

A recent report by Grand View Research analyzes the shortage of skilled medical staff and how this is expected to accelerate the market penetration rate of point-of-care (POC) diagnostic products (http://nnw.fm/NB6pp). The major advantage of these devices is that they can be operated by both qualified medical professionals and non-medical personnel with minimal training. Through its joint venture ownership of MIDS Medical Limited (MML), Zenosense, Inc. (OTC: ZENO) is developing “MIDS”, a nano-magnetic detection technology to allow true laboratory accuracy at the POC. This groundbreaking technology, if successfully embodied in a POC device, strongly positions Zenosense to capitalize on the predicted global growth in this market.

In the United States, development funding for diagnostics is being provided by many institutions, including the…

Read More>>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office